AIM: To investigate the prognostic significance of estrogen receptor 1 (ER1) and vascular endothelial growth factor A (VEGF-A) expression in primary gallbladder carcinoma (GBC) to identify new prognostic markers for this malignancy. METHODS: Using immunohistochemistry, we investigated ER1 and VEGF-A expression in 78 GBC and 78 cholelithiasis (CS) tissues. The results were correlated with clinicopathological features. Univariate and multivariate analyses were performed to evaluate the relationship between ER1 and VEGF-A expression and patients' prognosis. Further Kaplan-Meier survival analysis was also performed. RESULTS: ER1 and VEGF-A expression was significantly higher in GBC compared with CS (47/78 vs 28/78, P<0.05; 51/78 vs 33/78, P<0.05). ER1 expression was correlated with gender (P<0.05) and VEGF-A expression was correlated with tumor differentiation in GBC patients (P<0.05). In univariate analysis, age and tumor node metastasis (TNM) stage were factors associated with GBC prognosis (P<0.05). Although there was no statistical difference between the expression of ER1 or VEGF-A and overall survival, the high expression of ER1 combined with VEGF-A predicted a poor prognosis for GBC patients (16.30±1.87 vs 24.97±2.09, log-rank P<0.05). In multivariate analysis, combined expression of ER1 and VEGF-A and TNM stage were independent prognostic factors for GBC patients (P<0.05). CONCLUSION: Combined expression of ER1 and VEGF-A is a potential prognostic marker for GBC patients. Clinical detection of ER1 and VEGF-A in surgically resected GBC tissues would provide an important reference for decision-making of postoperative treatment programs.
AIM: To investigate the prognostic significance of estrogen receptor 1 (ER1) and vascular endothelial growth factor A (VEGF-A) expression in primary gallbladder carcinoma (GBC) to identify new prognostic markers for this malignancy. METHODS: Using immunohistochemistry, we investigated ER1 and VEGF-A expression in 78 GBC and 78 cholelithiasis (CS) tissues. The results were correlated with clinicopathological features. Univariate and multivariate analyses were performed to evaluate the relationship between ER1 and VEGF-A expression and patients' prognosis. Further Kaplan-Meier survival analysis was also performed. RESULTS:ER1 and VEGF-A expression was significantly higher in GBC compared with CS (47/78 vs 28/78, P<0.05; 51/78 vs 33/78, P<0.05). ER1 expression was correlated with gender (P<0.05) and VEGF-A expression was correlated with tumor differentiation in GBC patients (P<0.05). In univariate analysis, age and tumor node metastasis (TNM) stage were factors associated with GBC prognosis (P<0.05). Although there was no statistical difference between the expression of ER1 or VEGF-A and overall survival, the high expression of ER1 combined with VEGF-A predicted a poor prognosis for GBC patients (16.30±1.87 vs 24.97±2.09, log-rank P<0.05). In multivariate analysis, combined expression of ER1 and VEGF-A and TNM stage were independent prognostic factors for GBC patients (P<0.05). CONCLUSION: Combined expression of ER1 and VEGF-A is a potential prognostic marker for GBC patients. Clinical detection of ER1 and VEGF-A in surgically resected GBC tissues would provide an important reference for decision-making of postoperative treatment programs.
Authors: D Alvaro; G Alpini; P Onori; L Perego; G Svegliata Baroni; A Franchitto; L Baiocchi; S S Glaser; G Le Sage; F Folli; E Gaudio Journal: Gastroenterology Date: 2000-12 Impact factor: 22.682
Authors: S M Hyder; J C Huang; Z Nawaz; H Boettger-Tong; S Mäkelä; C Chiappetta; G M Stancel Journal: Environ Health Perspect Date: 2000-10 Impact factor: 9.031
Authors: V Sica; E Nola; E Contieri; R Bova; M T Masucci; N Medici; A Petrillo; A Weisz; A M Molinari; G A Puca Journal: Cancer Res Date: 1984-10 Impact factor: 12.701
Authors: Hector Alvarez; Alejandro Corvalan; Juan C Roa; Pedram Argani; Francisco Murillo; Jennifer Edwards; Robert Beaty; Georg Feldmann; Seung-Mo Hong; Michael Mullendore; Ivan Roa; Luis Ibañez; Fernando Pimentel; Alfonso Diaz; Gregory J Riggins; Anirban Maitra Journal: Clin Cancer Res Date: 2008-05-01 Impact factor: 12.531
Authors: A Mancino; M G Mancino; S S Glaser; G Alpini; A Bolognese; L Izzo; H Francis; P Onori; A Franchitto; S Ginanni-Corradini; E Gaudio; D Alvaro Journal: Dig Liver Dis Date: 2008-04-18 Impact factor: 4.088
Authors: Pablo Letelier; Patricia Garcia; Pamela Leal; Carmen Ili; Kurt Buchegger; Ismael Riquelme; Alejandra Sandoval; Oscar Tapia; Juan C Roa Journal: Appl Immunohistochem Mol Morphol Date: 2014-08